Quantum X Labs (QXL) Co-CEO exercises pre-funded warrant for 246,387 shares

Rhea-AI Filing Summary

QUANTUM X LABS INC. Co-CEO Baranes Yakov exercised a pre-funded warrant to acquire 246,387 shares of common stock on May 31, 2026. The shares were obtained at an exercise price of $0.0001 per share on a cashless basis, and no shares were withheld for taxes or fees.

Following the exercise, his directly held common stock position increased to 353,177 shares. The corresponding pre-funded warrant for 246,387 underlying shares was fully exercised and now shows zero remaining derivative balance.

Insights

Equity compensation analyst

Co-CEO converts pre-funded warrant into common shares in a routine, non-selling move.

Co-CEO Baranes Yakov exercised a pre-funded warrant covering 246,387 common shares of QUANTUM X LABS INC.. The exercise price was $0.0001 per share and was settled on a cashless basis, so no shares were withheld.

The Form 4 shows this as an in-the-money derivative exercise, moving exposure from a Pre-Funded Warrant into outright common stock. After the transaction, Yakov directly holds 353,177 common shares, and the specific warrant position is fully exhausted, with no remaining derivative balance from that instrument.

Because there were no reported open-market sales or tax-withholding dispositions, this looks like a standard exercise-and-hold style transaction. Its significance for investors depends on how 353,177 shares compare to the company’s overall share count, which is not detailed in this excerpt.

Insider Trade Summary

246,387 shares exercised/converted

Mixed 2 txns

Insider Baranes Yakov

Role Co-CEO

Type	Security	Shares	Price	Value
X	Pre-Funded Warrant to purchase common stock	246,387	$0.00	--
X	Common Stock, par value $0.0001 per share	246,387	$0.0001	$24.64

Holdings After Transaction: Pre-Funded Warrant to purchase common stock — 0 shares (Direct, null); Common Stock, par value $0.0001 per share — 353,177 shares (Direct, null)

Footnotes (1)

1. On May 31, 2026, the Reporting Person exercised a pre-funded warrant to purchase 246,387 shares of common stock of Quantum X Labs Inc. The Reporting Person paid the exercise price on a cashless basis, which did not result in the withholding of any shares. The Pre-Funded Warrants will not expire until exercised in full.

Key Figures

Shares acquired via exercise: 246,387 shares Exercise price: $0.0001 per share Post-transaction holdings: 353,177 shares +2 more

5 metrics

Shares acquired via exercise 246,387 shares Common stock from pre-funded warrant exercise on May 31, 2026

Exercise price $0.0001 per share Pre-funded warrant exercise price

Post-transaction holdings 353,177 shares Common stock directly held after the transaction

Exercised warrant size 246,387 underlying shares Pre-Funded Warrant to purchase common stock

Derivative balance after exercise 0 warrants Total shares following transaction for the pre-funded warrant

Key Terms

Pre-Funded Warrant, cashless basis, in-the-money derivative exercise, exercise price, +1 more

5 terms

Pre-Funded Warrant financial

"Pre-Funded Warrant to purchase common stock"

A pre-funded warrant is a financial instrument that gives the holder the right to buy shares of a company's stock at a set price, with most of the purchase cost already paid upfront. It functions like a nearly fully paid option, allowing investors to secure shares quickly while minimizing the amount of additional money they need to invest later. This helps investors gain ownership rights efficiently, often used to avoid certain regulatory restrictions or to prepare for future stock purchases.

cashless basis financial

"The Reporting Person paid the exercise price on a cashless basis"

An agreement executed on a cashless basis lets a holder convert or exercise a security (like options, warrants, or conversion rights) without paying money upfront; instead the holder receives a smaller number of shares equal in value to what the cash would have purchased. Think of trading a coupon for fewer slices of a cake rather than handing over cash for the full slice. For investors, it affects how much ownership and dilution occur and avoids immediate cash outlays.

in-the-money derivative exercise financial

"transaction_action: in-the-money derivative exercise"

exercise price financial

"paid the exercise price on a cashless basis"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

Common Stock financial

"Common Stock, par value $0.0001 per share"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Baranes Yakov

(Last) (First) (Middle)

C/O QUANTUM X LABS INC.

2 JABOTINSKY ST, 18TH FL

(Street)

RAMAT GAN L3 5252903

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
QUANTUM X LABS INC. [ QXL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Co-CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.0001 per share	05/31/2026		X		246,387	A	$0.0001(1)	353,177	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Pre-Funded Warrant to purchase common stock	$0.0001	05/31/2026		X			246,387	03/04/2026	(2)	Common Stock	246,387	$0	0	D

Explanation of Responses:

1. On May 31, 2026, the Reporting Person exercised a pre-funded warrant to purchase 246,387 shares of common stock of Quantum X Labs Inc. The Reporting Person paid the exercise price on a cashless basis, which did not result in the withholding of any shares.

2. The Pre-Funded Warrants will not expire until exercised in full.

	/s/ Yakov Baranes	06/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Quantum X Labs (QXL) report for Baranes Yakov?

Quantum X Labs (QXL) reported that Co-CEO Baranes Yakov exercised a pre-funded warrant for 246,387 common shares. The transaction converted derivative exposure into directly held stock without any reported open-market sales or share withholding.

How many Quantum X Labs (QXL) shares did the Co-CEO acquire in this Form 4?

The Co-CEO acquired 246,387 shares of Quantum X Labs common stock through the exercise of a pre-funded warrant. These shares were obtained at an exercise price of $0.0001 per share, executed on a cashless basis according to the filing footnote.

What is the exercise price of the pre-funded warrant in the Quantum X Labs (QXL) Form 4?

The pre-funded warrant in the Quantum X Labs Form 4 carried an exercise price of $0.0001 per share. The filing notes that the Co-CEO exercised this warrant on a cashless basis, so the low exercise price did not result in any share withholding.

How many Quantum X Labs (QXL) shares does the Co-CEO hold after the transaction?

After exercising the pre-funded warrant, the Co-CEO directly holds 353,177 shares of Quantum X Labs common stock. This figure reflects his position immediately following the reported May 31, 2026 transaction in the Form 4 filing.

Were any Quantum X Labs (QXL) shares sold or withheld in this Form 4 transaction?

No sales or withholding are reported in this Form 4. The filing explains that the pre-funded warrant’s exercise was completed on a cashless basis, and it explicitly states that this did not result in the withholding of any shares from the Co-CEO.

What happened to the pre-funded warrant position in Quantum X Labs (QXL) after exercise?

The pre-funded warrant covering 246,387 underlying Quantum X Labs common shares was fully exercised and now shows zero remaining balance. A footnote adds that such warrants do not expire until exercised in full, which occurred in this reported transaction.